The three most common nervous system disorders by global health impact are stroke, migraine, and dementia. According to a 2024 World Health Organization report analyzing data from 2021, these conditions top the list of neurological disorders causing the greatest loss of health worldwide, affecting well over a billion people combined. More than one in three people globally live with some form of neurological condition, making these disorders the leading cause of illness and disability on the planet.
Stroke
Stroke ranks as the single most burdensome neurological condition in the world. In 2021, roughly 11.9 million people had a new stroke, nearly 93.8 million were living with the effects of a prior stroke, and over 7 million died from one. Those numbers make stroke not just the most impactful nervous system disorder but one of the leading causes of death overall.
A stroke happens when blood flow to part of the brain is cut off. In the most common type, called an ischemic stroke, a clot blocks an artery supplying the brain. In a hemorrhagic stroke, a blood vessel in the brain ruptures and bleeds into surrounding tissue. Both types kill brain cells within minutes, which is why stroke is treated as a time-sensitive emergency. The faster blood flow is restored, the less permanent damage occurs.
The warning signs follow the acronym FAST: face drooping on one side, arm weakness, slurred speech, and time to call emergency services. Other signs include sudden confusion, trouble seeing in one or both eyes, severe headache with no known cause, and difficulty walking or maintaining balance. These symptoms appear abruptly, not gradually, which distinguishes stroke from most other neurological conditions.
Many of the biggest risk factors for stroke are things you can change. High blood pressure is the single largest contributor. Smoking, diabetes, physical inactivity, heavy alcohol use, and diets high in processed food all raise risk significantly. Managing blood pressure alone prevents more strokes than any other single intervention. For people who survive a stroke, recovery varies widely. Some regain most function within weeks, while others deal with lasting difficulties in speech, movement, or cognition that require months or years of rehabilitation.
Migraine
Migraine affects approximately 14% of the global population every year, making it one of the most widespread neurological conditions on Earth. It ranked third in overall health burden among all nervous system disorders in 2021, largely because it strikes people during their most productive years and can be profoundly disabling during attacks.
Migraine is not simply a bad headache. It is a complex neurological event that typically involves moderate to severe throbbing pain on one side of the head, nausea or vomiting, and extreme sensitivity to light and sound. Many people experience a prodrome phase hours or even a day before the pain starts, with symptoms like mood changes, food cravings, neck stiffness, or frequent yawning. About a quarter of people with migraine also get an aura, which can include visual disturbances like zigzag lines or temporary blind spots, tingling in the face or hands, or difficulty speaking.
Attacks can last anywhere from four hours to three days. During that window, normal activities become difficult or impossible. The economic toll reflects this: in Europe alone, migraine accounts for an estimated 117 billion euros in annual productivity losses, dwarfing its direct healthcare costs of around 9 billion euros. Most of the financial damage comes not from hospital visits but from missed workdays and reduced performance.
Migraine triggers vary from person to person but commonly include stress, hormonal shifts (particularly around menstruation), disrupted sleep, alcohol, certain foods, and changes in weather or barometric pressure. Treatment falls into two categories: medications taken during an attack to stop or reduce symptoms, and preventive treatments taken regularly to reduce how often attacks occur. For people with frequent or severe episodes, preventive treatment can cut attack frequency substantially. Newer therapies that target a specific protein involved in migraine pain signaling have expanded options for people who don’t respond well to older preventive medications.
Dementia and Alzheimer’s Disease
Dementia is not a single disease but a group of conditions characterized by progressive decline in memory, thinking, and the ability to perform everyday tasks. Alzheimer’s disease is the most common form, accounting for 60 to 70% of all dementia cases. Dementia ranked in the top ten neurological conditions for global health burden in 2021, and its impact is growing as populations age worldwide.
In Alzheimer’s disease, two types of abnormal protein buildup damage the brain. The first involves clumps of a protein fragment called beta-amyloid that accumulate between nerve cells, forming plaques that disrupt normal cell function. The second involves a protein called tau, which normally helps maintain the internal structure of nerve cells. In Alzheimer’s, tau detaches from these support structures, clumps together into tangles inside neurons, and blocks the cell’s transport system. This shuts down communication between nerve cells. Current evidence suggests that once beta-amyloid reaches a critical level, it triggers a rapid spread of tau tangles throughout the brain, accelerating the damage.
Early symptoms are often subtle and easy to dismiss. Repeating questions, misplacing items, forgetting recent conversations, and difficulty with familiar tasks like managing finances or following a recipe are typical early signs. As the disease progresses, people may become confused about time and place, have trouble recognizing family members, experience personality changes, and eventually lose the ability to carry out basic daily activities like dressing or eating independently. The progression from early symptoms to severe disability typically spans several years, though the timeline varies considerably.
Age is the strongest risk factor, with the likelihood roughly doubling every five years after age 65. Family history and certain genetic variations also increase risk. Modifiable factors play a role too: cardiovascular health, physical activity, social engagement, and management of conditions like diabetes and high blood pressure all influence dementia risk. There is no cure, but some treatments can temporarily slow symptom progression, and supportive care strategies can meaningfully improve quality of life for both patients and caregivers.
Why These Three Dominate
Stroke, migraine, and dementia sit at the top of global neurological burden for different reasons. Stroke kills and disables suddenly. Migraine affects an enormous share of the population during peak working years. Dementia erodes independence slowly over years, placing sustained pressure on families and healthcare systems. Together, they account for a disproportionate share of the disability caused by all neurological conditions combined.
Other conditions round out the broader picture. Diabetic neuropathy, which involves nerve damage from chronically high blood sugar, has more than tripled in prevalence since 1990, reaching 206 million cases in 2021. Epilepsy, meningitis, and autism spectrum disorder also rank among the top ten neurological conditions by health impact. But in terms of the sheer volume of people affected and the total years of healthy life lost, stroke, migraine, and dementia consistently lead the list.